395 related articles for article (PubMed ID: 8424421)
1. The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin.
Richards RD; Davenport K; McCallum RW
Am J Gastroenterol; 1993 Feb; 88(2):203-7. PubMed ID: 8424421
[TBL] [Abstract][Full Text] [Related]
2. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies.
Janssens J; Peeters TL; Vantrappen G; Tack J; Urbain JL; De Roo M; Muls E; Bouillon R
N Engl J Med; 1990 Apr; 322(15):1028-31. PubMed ID: 2320062
[TBL] [Abstract][Full Text] [Related]
3. Effect of intravenous administration of EM523L on gastric emptying and plasma glucose levels after a meal in patients with diabetic gastroparesis: a pilot study.
Nakamura T; Ishii M; Arai Y; Tandoh Y; Terada A; Takebe K
Clin Ther; 1994; 16(6):989-99. PubMed ID: 7697695
[TBL] [Abstract][Full Text] [Related]
4. Effect of oral erythromycin on patients with diabetic gastroparesis.
Pan DY; Chen GH; Chang CS; Ho KS; Poon SK; Huang CK; Kao CH; Wang SJ
Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jun; 55(6):447-51. PubMed ID: 7634182
[TBL] [Abstract][Full Text] [Related]
5. Effect of erythromycin on gastric and gallbladder emptying and gastrointestinal symptoms in scleroderma patients is maintained medium term.
Fiorucci S; Distrutti E; Gerli R; Morelli A
Am J Gastroenterol; 1994 Apr; 89(4):550-5. PubMed ID: 8147358
[TBL] [Abstract][Full Text] [Related]
6. Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis - a randomized, multicentre, placebo-controlled study.
McCallum RW; Cynshi O;
Aliment Pharmacol Ther; 2007 Oct; 26(8):1121-30. PubMed ID: 17894654
[TBL] [Abstract][Full Text] [Related]
7. Effects of mitemcinal (GM-611), an orally active erythromycin-derived prokinetic agent, on delayed gastric emptying and postprandial glucose in a new minipig model of diabetes.
Ozaki K; Monnai M; Onoma M; Muramatsu H; Yogo K; Watanabe T; Oda Y; Katagiri K; Arakawa H; Itoh Z; Omura S; Takanashi H
J Diabetes Complications; 2008; 22(5):339-47. PubMed ID: 18413164
[TBL] [Abstract][Full Text] [Related]
8. Mitemcinal (GM-611), an orally active motilin receptor agonist, improves delayed gastric emptying in a canine model of diabetic gastroparesis.
Onoma M; Ozaki K; Yogo K; Monnai M; Muramatsu H; Kamei K; Kawabe Y; Hayashi S; Shiga T; Matsuo S; Suzuki M; Itoh Z; Omura S; Takanashi H
Clin Exp Pharmacol Physiol; 2008 Jul; 35(7):788-96. PubMed ID: 18346169
[TBL] [Abstract][Full Text] [Related]
9. Gastric emptying and gastric myoelectrical activity in patients with diabetic gastroparesis: effect of long-term domperidone treatment.
Koch KL; Stern RM; Stewart WR; Vasey MW
Am J Gastroenterol; 1989 Sep; 84(9):1069-75. PubMed ID: 2773901
[TBL] [Abstract][Full Text] [Related]
10. Comparison of metoclopramide and erythromycin in the treatment of diabetic gastroparesis.
Erbas T; Varoglu E; Erbas B; Tastekin G; Akalin S
Diabetes Care; 1993 Nov; 16(11):1511-4. PubMed ID: 8299441
[TBL] [Abstract][Full Text] [Related]
11. Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs.
Onoma M; Yogo K; Ozaki K; Kamei K; Akima M; Koga H; Itoh Z; Omura S; Takanashi H
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):35-42. PubMed ID: 18047625
[TBL] [Abstract][Full Text] [Related]
12. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis.
Tack J; Depoortere I; Bisschops R; Verbeke K; Janssens J; Peeters T
Aliment Pharmacol Ther; 2005 Nov; 22(9):847-53. PubMed ID: 16225494
[TBL] [Abstract][Full Text] [Related]
13. Effect of the motilin agonist KC 11458 on gastric emptying in diabetic gastroparesis.
Russo A; Stevens JE; Giles N; Krause G; O'Donovan DG; Horowitz M; Jones KL
Aliment Pharmacol Ther; 2004 Aug; 20(3):333-8. PubMed ID: 15274670
[TBL] [Abstract][Full Text] [Related]
14. Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle.
Miller LS; Szych GA; Kantor SB; Bromer MQ; Knight LC; Maurer AH; Fisher RS; Parkman HP
Am J Gastroenterol; 2002 Jul; 97(7):1653-60. PubMed ID: 12135014
[TBL] [Abstract][Full Text] [Related]
15. The effect of intravenous erythromycin on solid meal gastric emptying in patients with chronic symptomatic post-vagotomy-antrectomy gastroparesis.
Kendall BJ; Chakravarti A; Kendall E; Soykan I; McCallum RW
Aliment Pharmacol Ther; 1997 Apr; 11(2):381-5. PubMed ID: 9146779
[TBL] [Abstract][Full Text] [Related]
16. The effect of sildenafil on gastric emptying in patients with end-stage renal failure and symptoms of gastroparesis.
Dishy V; Cohen Pour M; Feldman L; Naftali T; Baumer M; Efrati S; Golik A; Horne T; Weissgarten J
Clin Pharmacol Ther; 2004 Sep; 76(3):281-6. PubMed ID: 15371988
[TBL] [Abstract][Full Text] [Related]
17. Dose-related effects of N-demethyl-N-isopropyl-8, 9-anhydroerythromycin A 6,9-hemiacetal on gastric emptying of solids in healthy human volunteers.
Choi MG; Camilleri M; Burton DD; Johnson S; Edmonds A
J Pharmacol Exp Ther; 1998 Apr; 285(1):37-40. PubMed ID: 9535992
[TBL] [Abstract][Full Text] [Related]
18. Effects of low doses of erythromycin on the 13C Spirulina platensis gastric emptying breath test and electrogastrogram: a controlled study in healthy volunteers.
DiBaise JK; Park FL; Lyden E; Brand RE; Brand RM
Am J Gastroenterol; 2001 Jul; 96(7):2041-50. PubMed ID: 11467630
[TBL] [Abstract][Full Text] [Related]
19. Glucose control is not improved by accelerating gastric emptying in patients with type 1 diabetes mellitus and gastroparesis. a pilot study with cisapride as a model drug.
Lehmann R; Honegger RA; Feinle C; Fried M; Spinas GA; Schwizer W
Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):255-61. PubMed ID: 12951630
[TBL] [Abstract][Full Text] [Related]
20. Metoclopramide therapy in fifty-five patients with delayed gastric emptying.
Perkel MS; Hersh T; Moore C; Davidson ED
Am J Gastroenterol; 1980 Sep; 74(3):231-6. PubMed ID: 7468558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
